Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function-Reference-Cited by-同舟云学术

Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function

Published:1985 Issue:3 Volume:28 Page:327-331
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Takabatake T.,Ohta H.,Maekawa M.,Yamamoto Y.,Ishida Y.,Hara H.,Nakamura S.,Ushiogi Y.,Kawabata M.,Hashimoto N.,Hattori N.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00543332.pdf

Reference13 articles.

1. Takagi T, Takada M, Maeno H (1982) Effect of a new potent H2-blocker, 3-[[[ 2-[(diaminomethylene)amino]-4-thiazolyl] methyl]-thio]-N2sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Arch Int Pharmacodyn Ther 256: 49?58

2. Miwa M, Tani N, Miwa T (1984) Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects. Int J Clin Pharmacol Ther Toxicol 22: 214?217

3. Kawai R, Yamada S, Kawamura S, Miwa T, Miwa M (1984) Pharmacokinetics of famotidine (YM-11170), a new histamine H2-receptor antagonist. Part 2: Absorption and excretion in dogs and humans. Ohyo Yakuri (Pharmacometrics) 27 [1]: 73?77

4. Ventkateswaran PS, Jeffers A, Hocken AG (1972) Gastric acid secretion in chronic renal failure. Br Med J 4: 22?23

5. Shepherd AMM, Stewart WK, Wormsley KG (1973) Peptic ulceration in chronic renal failure. Lancet 1: 1357?1359

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihistamines;Pharmacology in Veterinary Anesthesia and Analgesia;2024-03-08

2. Comparison of the acid suppression effects between low-dose esomeprazole and famotidine in healthy subjects;Int. Journal of Clinical Pharmacology and Therapeutics;2023-09-01

3. Fabrication and Characterization of Famotidine Solid Lipid Nanoparticles Using Hot Emulsification Method for Bioavailability Enhancement;International Journal of Pharmaceutical Investigation;2022-03-10

4. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series;Gut;2020-06-04

5. PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters;Clinical Pharmacology & Therapeutics;2017-07-24